The Campaign Landscape Analysis conducted in 2019 identified several challenges to the current campaign ecosystem and opportunities to improve effectiveness, reach target populations and disease goals. When the COVID-19 pandemic suspended or delayed at least 287 of the 566 planned campaigns in 2020 (see COVID-19 campaign impact tracker), it impacted countries’ ability to reach communities in need of services as well as opened opportunities to rethink how campaigns are planned, implemented and evaluated. The rollout of the COVID-19 vaccines presents new possibilities to leverage existing campaign platforms and partnerships to reach at-risk communities and improve campaign quality, effectiveness and efficiencies.
What approaches and tools have been successful in improving campaign effectiveness, efficiency and quality?
- What measures/metrics should be used to monitor and evaluate outcomes and whether campaigns are reaching “zero dose” and “never-treated” communities?
What lessons have been learned about how to plan and deliver health campaigns during the COVID-19 pandemic?
- Which of these new approaches or methods will continue to be practiced beyond the pandemic?
How can the lessons learned from existing campaign platforms inform and support the planning and delivery of COVID-19 vaccines?
- What has been the impact of the COVID-19 vaccine rollout on campaigns for NTDs, polio, VPDs, malaria, VAS (e.g., negative impacts due to workforce prioritized for COVID vaccine delivery or positive impacts such as strengthening microplans, surveillance and other HIS, training, identification of hard to reach populations)?